Skip to main content

Table 1 Subgroup specification of BLCA patients with WWOX, TFAP2A and TFAP2C expression levels

From: In vitro and in silico assessment of the effect of WWOX expression on invasiveness pathways associated with AP-2 transcription factors in bladder cancer

Group

Number of patients

WWOX

TFAP2A

TFAP2C

A

58

Low

High

High

B

84

Low

Low

Low

C

37

High

High

High

D

38

High

Low

Low

E

24

High

High

Low

F

47

High

Low

High

G

39

Low

High

Low

H

81

Low

Low

High